Lidocaine Hydrochloride And Dextrose Injection, Solution
Product Images NDC 84549-594

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Dextrose (NDC 84549-594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 594 20)

Label (84549 594 20)
This text provides crucial information about Lidocaine HCI (PF) / Dextrose IV Solution. It contains details such as the concentration (5%, 4mg/mL), volume (250mL Bag), manufacturer information (B. Braun Medical Inc.), storage conditions (Room Temperature), and usage instructions (intravenous use only, do not admix with other drugs). Additionally, it includes important warnings such as not to administer simultaneously with blood, not to use in series connection, among other precautions. The text mentions lot numbers, expiration dates, and a reference to the USP Controlled Room Temperature standards.*
FDA Label Image

Chemical Structure (Lidocaine Hydrochloride And Dextrose Injection Usp 1)

FDA Label Image

Chemical Structure (Lidocaine Hydrochloride And Dextrose Injection Usp 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.